British Journal of Ophthalmology 2002;86:181-184
© 2002 British Journal of Ophthalmology
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
Pasquale Aragona1,
Vincenzo Papa3,
Antonio Micali2,
Marcello Santocono3,
Giovanni Milazzo3
1 Institute of Ophthalmology, University of Messina, Italy
2 Department of Biomorphology, University of Messina, Italy
3 Clinical Department SIFI SpA, Lavinaio-Catania, Italy
Correspondence to:
Correspondence to:
Dr Giovanni Milazzo, SIFI SpA, Clinical Research Department, Via Ercole Patti, 36, Lavinaio (CT)-95020, Italy;
giovanni_milazzo{at}sifi.it
Background/aims: Several studies have reported that sodium hyaluronate is able to improve both symptoms and signs in patients with dry eye but none have demonstrated an improvement of conjunctival epithelial cell abnormalities of the ocular surface. The aim of this study was to explore the effect of sodium hyaluronate-containing eye drops on the ocular surface of patients with dry eye during long term treatment.
Methods: A randomised double blind study was undertaken in 86 patients with medium to severe dry eye (that is, rose bengal and/or fluorescein test score of at least 3, tear film break up time <10 seconds, or Schirmer's test <5.5 mm). Patients were treated with either preservative-free sodium hyaluronate or saline for 3 months at a dose of one drop 4–8 times a day. Bulbar impression cytology, slit lamp examinations, and subjective symptoms were evaluated after 1, 2, and 3 months. Impression cytology was considered the primary efficacy parameter of the study.
Results: The efficacy analysis was performed on a total of 44 patients who were able to fully adhere to the protocol. After 3 months of treatment sodium hyaluronate improved impression cytology score (p = 0.024 v baseline). At the same time also the difference with respect to placebo was statistically significant (p = 0.036). Study medication was well tolerated and no treatment related adverse events occurred during the study.
Conclusions: Sodium hyaluronate may effectively improve ocular surface damage associated with dry eye syndrome.
Keywords: hyaluronic acid; dry eye; impression cytology
This article has been cited by other articles:
|
|
|
|
 
H Mochizuki, M Yamada, S Hato, and T Nishida
Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid
Br. J. Ophthalmol.,
January 1, 2008;
92(1):
108 - 111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Y. Oh, Y. S. In, M. K. Kim, J. H. Ko, H. J. Lee, K. C. Shin, S. M. Lee, W. R. Wee, J. H. Lee, and M. Park
Protective Effect of Uridine on Cornea in a Rabbit Dry Eye Model
Invest. Ophthalmol. Vis. Sci.,
March 1, 2007;
48(3):
1102 - 1109.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Prabhasawat, N Tesavibul, and N Kasetsuwan
Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study
Br. J. Ophthalmol.,
January 1, 2007;
91(1):
47 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J A P Gomes, R Amankwah, A Powell-Richards, and H S Dua
Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro
Br. J. Ophthalmol.,
June 1, 2004;
88(6):
821 - 825.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Horwath-Winter, A. Berghold, O. Schmut, I. Floegel, V. Solhdju, E. Bodner, G. Schwantzer, and E.-M. Haller-Schober
Evaluation of the Clinical Course of Dry Eye Syndrome
Arch Ophthalmol,
October 1, 2003;
121(10):
1364 - 1368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Aragona, G Di Stefano, F Ferreri, R Spinella, and A Stilo
Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients
Br. J. Ophthalmol.,
August 1, 2002;
86(8):
879 - 884.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
